AxoGen’s revenue increased from $2 million in 2012’s second quarter to $2.9 million. Company executives attributed the gain to an increased number of facilities using AxoGen’s products.
The company’s net loss jumped from $3.1 million to $6.9 million, due in part to increased interest costs. The company paid $1.8 million in interest added to the note after having paid no interest the year prior.
More Articles on Devices:
Aesculap’s Quintex Anterior Cervical Spine Plating System Now Available
SpineVision Names Ken Yamada as US Subsidiary COO
Orthozon Technologies Launches Lumiere Retractor for Minimally Invasive Discectomy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
